Contact this trialFirst, we need to learn more about you.
Virus Therapy
Viral Replicon Particles for Head and Neck Cancer
Recruiting1 awardPhase 1
Stanford, California
This trial aims to test the safety of injecting a virus replicon particle containing saRNA encoding IL-12 directly into head and neck cancer tumors. They want to see how the tumors respond to this treatment
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service